You are invited to participate in the Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP) to be held at the Fairmont Scottsdale Princess on May 28-31, 2019 by submitting a proposal and attending the meeting. The committee welcomes submissions from the U.S. as well as international proposals, and this year the committee strongly encourages the composition of panels and workshops that include women, under-represented minorities and early career scientists and clinicians. 

This year's meeting theme is “ Innovations in Personalized Medicine: From Biomarkers to Patient-Centered Care.

The Program Committee is especially interested in proposals on the topics below but welcomes all submissions.
  • Translational Research into Clinical Practice
  • Patient-focused Drug Development
  • Genomics
  • Use of Biomarkers in RCTs
  • Technology Advancements and Potential for Assessing Behavior
  • Use of Personalized Devices and/or Apps
  • Changes in Digital Phenotyping or Analytical Approaches to Data
  • Ethical or Privacy Concerns in Behavioral Research 
  • Outcome Measures in Trials 
  • VA Million Veteran Cohort

Detailed instructions to submit your abstracts are available at .
  2019 Submission Deadlines:

New Investigator Awards : January 28, 2019
Posters : January 28, 2019
Individual Research Reports : January 28, 2019
The 2019 meeting will again include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Susan Kornstein and John Newcomer with representation of the sectors that are part of the ASCP community will lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, and academia comprise the 2019 Steering Committee. A Program Committee under the leadership of Drs. Anita Clayton and Erika Saunders will be responsible for review of all program submissions.

Registration for the meeting will open in December, 2018.
Please visit for registration and housing details.
ASCP is accepting nominations to recognize two individuals for their contributions to clinical psychopharmacology. The  Donald Klein Lifetime Achievement Award  and the  Paul Wender Best Paper in The Journal of Clinical Psychiatry Award . The deadline for submission is January 14, 2019. Each winner will receive a $1,000 stipend and plaque to be given during the 2019 ASCP Annual Meeting. Each winner must be present at the 2019 ASCP Annual Meeting. Learn More
2019 ASCP Annual Meeting New Investigator Award (NIA) Program
ASCP recognizes that the vitality and success of most endeavors in medicine is directly related to the ability to attract and maintain a talented pool of clinical investigators. The ASCP Steering Committee is seeking applicants for the New Investigator Award (NIA) Program.

The New Investigators will be recognized at the 2019 ASCP Annual Meeting in Scottsdale, Arizona at the Fairmont Scottsdale Princess on May 28-31, 2019. The workshop will be held on Monday, May 27, 2019. The goals of the program are to expose awardees to the breadth of opportunities available to clinical researchers, introduce them to potential senior investigators from other institutions, and facilitate the establishment of a national peer group for the New Investigators. Learn More